Gaudium IVF IPO GMP Suggests 15% Listing Gain; Check Key Details

Gaudium IVF and Women Health Ltd. is set to launch its Initial Public Offering (IPO) on February 20, aiming to raise ₹165 crore. The IPO will have a price band ranging from ₹75 to ₹79 per share. Market analysts predict a listing gain of approximately 15%, reflecting strong investor interest in the company, which specializes in fertility treatments and women's health services. The anticipated positive listing comes as more investors are looking to capitalize on the growing healthcare sector in India, particularly in reproductive health. Gaudium IVF's entry into the stock market is expected to enhance its visibility and support its expansion plans, as demand for IVF and related services continues to rise in the country. Investors are urged to keep an eye on this offering, as it may present a lucrative opportunity amidst the evolving landscape of healthcare investments in India.